EP3288636A4 - Compositions for the treatment of epistaxis - Google Patents
Compositions for the treatment of epistaxis Download PDFInfo
- Publication number
- EP3288636A4 EP3288636A4 EP15891259.2A EP15891259A EP3288636A4 EP 3288636 A4 EP3288636 A4 EP 3288636A4 EP 15891259 A EP15891259 A EP 15891259A EP 3288636 A4 EP3288636 A4 EP 3288636A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- epistaxis
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/001451 WO2016178053A1 (en) | 2015-05-01 | 2015-05-01 | Compositions for the treatment of epistaxis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3288636A1 EP3288636A1 (en) | 2018-03-07 |
EP3288636A4 true EP3288636A4 (en) | 2019-01-16 |
Family
ID=57218149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15891259.2A Withdrawn EP3288636A4 (en) | 2015-05-01 | 2015-05-01 | Compositions for the treatment of epistaxis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3288636A4 (en) |
CN (1) | CN107073293A (en) |
CA (1) | CA2952818A1 (en) |
IL (1) | IL249640A0 (en) |
WO (1) | WO2016178053A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018248422B2 (en) * | 2017-04-04 | 2024-02-15 | Anti-Plasmin Technologies, Llc | Methods to enhance a non-surgical medical treatment |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
JP2022529781A (en) | 2019-04-17 | 2022-06-24 | コンパス パスファインダー リミテッド | Treatment of depression and various other disorders with psilocybin |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
MX2022014605A (en) | 2020-05-19 | 2022-12-16 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use. |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
KR20070046093A (en) * | 2004-07-09 | 2007-05-02 | 훼로산 아크티에 셀스카브 | Haemostatic composition comprising hyaluronic acid |
HUE046071T2 (en) * | 2009-10-30 | 2020-01-28 | Intratus Inc | Methods and compositions for sustained delivery of drugs |
US20150231300A1 (en) * | 2012-10-28 | 2015-08-20 | Peritech Pharma Ltd. | Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders |
US20140255522A1 (en) * | 2013-03-10 | 2014-09-11 | Peritech Pharma Ltd. | Topical compositions and methods of treatment of anorectal and genital disorders |
-
2015
- 2015-05-01 CN CN201580036043.8A patent/CN107073293A/en active Pending
- 2015-05-01 WO PCT/IB2015/001451 patent/WO2016178053A1/en active Application Filing
- 2015-05-01 EP EP15891259.2A patent/EP3288636A4/en not_active Withdrawn
- 2015-05-01 CA CA2952818A patent/CA2952818A1/en not_active Abandoned
-
2016
- 2016-12-19 IL IL249640A patent/IL249640A0/en unknown
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
CA2952818A1 (en) | 2016-11-10 |
EP3288636A1 (en) | 2018-03-07 |
CN107073293A (en) | 2017-08-18 |
WO2016178053A1 (en) | 2016-11-10 |
IL249640A0 (en) | 2017-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3448874A4 (en) | Compositions for the treatment of disease | |
EP3448875A4 (en) | Compositions for the treatment of disease | |
EP3448987A4 (en) | Compositions for the treatment of disease | |
EP3263132A4 (en) | Composition for treating il-6-related diseases | |
EP3240555A4 (en) | Multi-supplement compositions | |
EP3380199A4 (en) | Compositions for treating the hair | |
EP3380200A4 (en) | Compositions for treating the hair | |
EP3380062A4 (en) | Compositions for treating the hair | |
AU2016291708B2 (en) | Plinabulin compositions | |
EP3380063A4 (en) | Compositions for treating the hair | |
SI3524255T1 (en) | Composition for the treatment of acne | |
EP3248475A4 (en) | Composition | |
IL249640A0 (en) | Compositions for the treatment of epistaxis | |
TWI799397B (en) | Compositions for the treatment of hypertension | |
EP3344256A4 (en) | Compositions for the treatment of joints | |
EP3122349A4 (en) | Compositions for the treatment of autodigestion | |
EP3386593A4 (en) | Immunomodulating composition for treatment | |
EP3349766A4 (en) | Anti-hemorrhaging compositions | |
EP3288386A4 (en) | Anti-phytopathogenic compositions | |
EP3206670A4 (en) | Compositions for treating wounds | |
EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
EP3277256A4 (en) | Hair treatment compositions | |
EP3354284A4 (en) | Composition for treating pain | |
EP3315031A4 (en) | Composition | |
EP3294339A4 (en) | Methods and compositions for the treatment of arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20161219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20181219 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 11/02 20060101AFI20181213BHEP Ipc: A61K 9/06 20060101ALI20181213BHEP Ipc: A61K 31/4174 20060101ALI20181213BHEP Ipc: A61K 31/195 20060101ALI20181213BHEP Ipc: A61K 47/34 20170101ALI20181213BHEP Ipc: A61K 31/137 20060101ALI20181213BHEP Ipc: A61K 9/70 20060101ALI20181213BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20190719 |